Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2006-09-14
2009-02-24
Huynh, Phuong (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S141100, C424S142100, C424S178100, C424S184100, C424S193100
Reexamination Certificate
active
07494649
ABSTRACT:
The invention provides a liquid composition and a lyophilized composition comprising a therapeutically effective amount of a conjugate comprising an antibody chemically coupled to a maytansinoid. The invention further provides a method for killing a cell in a human comprising administering to the human either of the compositions such that the antibody binds to the surface of the cell and the cytotoxicity of the maytansinoid is activated, whereby the cell is killed.
REFERENCES:
patent: 3896111 (1975-07-01), Kupchen et al.
patent: 4151042 (1979-04-01), Higashide et al.
patent: 4563304 (1986-01-01), Carlsson et al.
patent: 5208020 (1993-05-01), Chari et al.
patent: 5225539 (1993-07-01), Winter
patent: 5416064 (1995-05-01), Chari et al.
patent: 5475092 (1995-12-01), Chari et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5639641 (1997-06-01), Pedersen et al.
patent: 5665357 (1997-09-01), Rose et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5714352 (1998-02-01), Jakobovits
patent: 6171586 (2001-01-01), Lam et al.
patent: 6265150 (2001-07-01), Terstappen et al.
patent: 6333410 (2001-12-01), Chari et al.
patent: 6340701 (2002-01-01), Chari et al.
patent: 6372738 (2002-04-01), Chari et al.
patent: 6436931 (2002-08-01), Chari et al.
patent: 6441163 (2002-08-01), Chari et al.
patent: 6716821 (2004-04-01), Zhao et al.
patent: 6756397 (2004-06-01), Zhao et al.
patent: 6824780 (2004-11-01), Devaux et al.
patent: 7097840 (2006-08-01), Erickson et al.
patent: 2001/0036923 (2001-11-01), Chari et al.
patent: 2002/0001587 (2002-01-01), Erickson et al.
patent: 2002/0041847 (2002-04-01), Goldenberg
patent: 2002/0197266 (2002-12-01), Debinski
patent: 2003/0004210 (2003-01-01), Chari et al.
patent: 0 239 400 (1994-08-01), None
patent: 2 188 638 (1987-10-01), None
patent: WO 97/04801 (1997-02-01), None
patent: WO 00/02587 (2000-01-01), None
patent: WO 01/00244 (2001-01-01), None
patent: WO 01/24763 (2001-04-01), None
patent: WO 01/38318 (2001-05-01), None
patent: WO 01/49698 (2001-07-01), None
patent: WO 02/16401 (2002-02-01), None
patent: WO 02/060955 (2002-08-01), None
patent: WO 02/092127 (2002-11-01), None
patent: WO 03/057163 (2003-07-01), None
patent: WO 03/097625 (2003-11-01), None
Lepage et al.,American Assn. for Cancer Research(AACR),2003 Annual Meeting, Poster Abstract 749.
Bartnes,Tidsskr. Nor. Laegforen., 121,2941-2945 (2001).
Behm et al.,Blood, 87, 1134-1139 (1996).
Carlsson et al.,Biochemical Journal, 173, 723-737 (1978).
Chang et al.,Cancer Res. 59, 3192-3198 (1999).
Colomer et al.,Cancer Investigation, 19 (1), 49-56 (2001).
Francisco et al.,Blood, 102 (4), 1458-1465 (2003).
Ghetie et al.,Journal of Immunological Methods, 112, 267-277 (1988).
Haskard et al.,J. Immunol. Methods, 74(2), 361-367 (1984).
Heider et al.,European Journal of Cancer, 31A (13/14), 2385-2391 (1995).
Huse et al.,Science, 246, 1275-1281 (1989).
Ichimura et al.,Journal of Antibiotics, 44 (10), 1045-1053 (1991).
Kearse et al.,Int. J. Cancer, 88, 866-872 (2000).
Kohler et al.,Eur. J. Immunol., 5, 511-519 (1976).
Kupchan et al.,Journal of Medicinal Chemistry, 21 (1), 31-37 (1978).
Liu et al.,Proc. Natl. Acad. Sci, 93, 8618-8623 (1996).
Maloney et al.,Blood, 90 (6), 2188-2195 (1997).
Miotti et al.,Int. J. Cancer, 39, 297-303 (1987).
Nadler et al.,Journal of Immunology, 131 (1), 244-250 (1983).
Pedersen et al.,Journal of Molecular Biology, 235 (3), 959-973 (1994).
Reiter et al.,Protein Engineering, 7 (5), 697-704 (1994).
Remillard et al.,Science, 189 (4207), 1002-1005 (1975).
Roder et al.,Methods Enzymol., 121, 140-167 (1986).
Roguska et al.,Proc. Natl. Acad. Sci., 91, 969-973 (1994).
Sasse et al.,Journal of Antibiotics, 53 (9), 879-885 (2000).
Suzawa et al.,Bioorganic and Medicinal Chemistry, 8, 2175-2184 (2000).
Von Mensdorff-Pouilly et al.,Int. J. Biol. Markers, 15, 343-356 (2000).
Wang,International Journal of Pharmaceutics, 203, 1-60 (2000).
Welt et al.,Journal of Clinical Oncology, 12 (6), 1193-1203 (1994).
Yoshitake et al.,European Journal of Biochemistry, 101, 395-399 (1979).
Amphlett Godfrey
Chih Hung-Wei
Fleming Michael
Zhang Wei
Huynh Phuong
ImmunoGen Inc.
Leydig , Voit & Mayer, Ltd.
LandOfFree
Drug conjugate composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug conjugate composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug conjugate composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4073379